Rockville, MD, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The global Clostridium difficile infection treatment market has been estimated at US$ 1.24 billion for 2024 and is projected to expand at a CAGR of ...
The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C.
Fact.MR, in its new offering, presents an unbiased analysis of the Clostridium difficile infection treatment market for 2018 to 2023 and forecast statistics for 2024 to 2034. The study divulges ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results